Cargando…
Epidemiology and Long-Term Survival in HIV-Infected Patients With Pneumocystis jirovecii Pneumonia in the HAART Era: Experience in a University Hospital and Review of the Literature
As highly active antiretroviral treatment (HAART) is widely available, the incidence of Pneumocystis jirovecii pneumonia (PJP) has decreased significantly but still represents a significant cause of morbidity and mortality in developed countries. We analyzed all the cases with PJP in human immunodef...
Autores principales: | López-Sánchez, Cristina, Falcó, Vicenç, Burgos, Joaquin, Navarro, Jordi, Martín, María Teresa, Curran, Adrià, Miguel, Lucía, Ocaña, Inma, Ribera, Esteve, Crespo, Manel, Almirante, Benito |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4553998/ https://www.ncbi.nlm.nih.gov/pubmed/25816039 http://dx.doi.org/10.1097/MD.0000000000000681 |
Ejemplares similares
-
Clinical Usefulness of HRCT in Assessing the Severity of Pneumocystis jirovecii Pneumonia: A Cross-sectional Study
por: Chou, Chung-Wei, et al.
Publicado: (2015) -
Assessment of cytomegalovirus and cell-mediated immunity for predicting outcomes in non-HIV-infected patients with Pneumocystis jirovecii pneumonia
por: Kim, Taeeun, et al.
Publicado: (2017) -
Differential cytology profiles in bronchoalveolar lavage (BAL) in COVID-19 patients: A descriptive observation and comparison with other corona viruses, Influenza virus, Haemophilus influenzae, and Pneumocystis jirovecii
por: Vedder, Vanessa, et al.
Publicado: (2021) -
Investigational and Experimental Drugs for Community-Acquired Pneumonia: the Current Evidence
por: Sellarès-Nadal, Juilia, et al.
Publicado: (2020) -
Health Care Associated Hematogenous Pyogenic Vertebral Osteomyelitis: A Severe and Potentially Preventable Infectious Disease
por: Pigrau, Carlos, et al.
Publicado: (2015)